Yes it is a WONDERFUL idea
That's a smart way you can be rich faster
I put a similar comment in BIIB's board. Let's assume that LLY achieves a moderate level effectiveness, has FDA approval of their Alzheimer's drug and prices it at whatever. Would this not be a very slow hanging slider for BIIB - with bases loaded. Their drug is about 2 years away i.e. early innings. The chance you take is that BIIB's Alzheimer's drug will not be as effective. This is a bigger blockbuster than HEPC.
This is sola, right? So, the NEJM said it was worthless but LLY reviews the data and says maybe, a little, for the "mild" group. Why would you jump in if it rallies for for the wrong reason?
You might triple your money with MNKD by the end of the year AND support the best insulin on the market!
Sentiment: Strong Buy
MNKD shares headed below $4 ..... total GARBAGE ! ..... Affreza was dead on arrival ...............
It is going to retun a lot of money in the end
friday's close and the alzheimer's group not posting early...don't look good. at first I thought the decision not to early post by the alzheimer's group was bullish...now I think it isn't but will see if the stock rallies as july approaches...if it does I may jump in
DTC on Afrezza begins July 1st... why doesn't LLY management partner with Mannkind (MNKD) to launch one it's longer term insulins (or other injectable and potent drug) using the Best in Class, Only in Class Technosphere with Dreamboat?
That's right just go Google it
How's that short working for you? You are consistently wrong! Your cheeks look a little tight? Tired of taking the AMBA missle ... you amateur!
It's true. Afrezza is a monomer, not a hexamer, so for mealtimes, it's perfect, gets absorbed immediately and then tapers off during the course of a meal to avoid the blood pressure spike.
Supporting MNKD is supporting mankind!